We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Drug Enforcement Administration (DEA) is allowing increased production and importation of some controlled medicines to address the surge in demand for drugs needed for COVID-19 patients on ventilators. Read More
A group of more than 30 consumer, health and trade organizations urged three dozen countries — including the U.S. — to allow imports of drugs manufactured under government-issued patent exemptions during the COVID-19 crisis. Read More
Queen’s University Belfast is leading a U.K.-wide clinical trial of allogenic Mesenchymal stromal cells (MSCs) for treatment of acute respiratory distress syndrome in COVID-19 patients. Read More
Global research charity Wellcome Trust is asking CEOs of multinational companies to help raise at least $8 billion by the end of the month to cover a worldwide “funding shortfall” for developing and manufacturing COVID-19 vaccines, treatments and diagnostics. Read More
The World Health Organization’s director-general has endorsed the voluntary sharing of patent rights and pooling of data to help develop COVID-19 drugs. Read More
Eli Lilly yesterday introduced a $35 monthly insulin co-pay for patients with or without commercial insurance to ensure they have access to the diabetes drug during the COVID-19 crisis. Read More
The Indian government said Tuesday that it will lift its newly imposed export restriction on the anti-malaria drug hydroxychloroquine, a potential COVID-19 treatment. Read More